| FAFGX | PABGX | FAFGX / PABGX | |
| Total Expense Ratio | 0.40 | 0.95 | 42% |
| Annual Report Gross Expense Ratio | 0.40 | 0.95 | 42% |
| Fund Existence | 5 years | 26 years | - |
| Gain YTD | 19.150 | 17.875 | 107% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 339B | 69.6B | 487% |
| Annual Yield % from dividends | 0.49 | 0.00 | - |
| Returns for 1 year | 7.30 | 7.04 | 104% |
| Returns for 3 years | 63.58 | 83.99 | 76% |
| Returns for 5 years | 34.45 | 31.66 | 109% |
| Returns for 10 years | N/A | 181.89 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MODL | 47.53 | 0.15 | +0.31% |
| VictoryShares WestEnd U.S. Sector ETF | |||
| GSLC | 132.06 | 0.21 | +0.16% |
| Goldman Sachs ActiveBeta® US LgCp Eq ETF | |||
| FIRS | 23.08 | N/A | N/A |
| FIRE Funds Wealth Builder ETF | |||
| HSCZ | 38.71 | -0.02 | -0.06% |
| iShares Currency Hdgd MSCI EAFE SmCp ETF | |||
| BBP | 77.29 | -0.86 | -1.10% |
| Virtus LifeSci Biotech Products ETF | |||